{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Katie", "organization": "", "rank": 1, "lastname": "THOMAS"}], "original": "By KATIE THOMAS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Food and Drug Administration delays until 2017 decision on whether to require generic drug companies to assume more responsibility for warning patients on labels about product risks.", "multimedia": [], "headline": {"print_headline": "F.D.A. Delays Decision on Generic Drug Labels", "main": "F.D.A. Delays Rule on Generic Drug Labels"}, "print_page": "2", "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Labeling and Labels (Product)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Generic Brands and Products", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Suits and Litigation (Civil)", "is_major": "N", "rank": "5", "name": "subject"}], "snippet": "Consumer groups had urged the agency to close a loophole that keeps patients harmed by generic drugs from suing manufacturers.", "source": "The New York Times", "lead_paragraph": "Consumer groups had urged the agency to close a loophole that keeps patients harmed by generic drugs from suing manufacturers.", "word_count": "614", "pub_date": "2016-05-20T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/05/20/business/fda-delays-rule-on-generic-drug-labels.html", "_id": "573e4c6038f0d8366bbdfea8"}